(Q37085132)

18 August 2017

1 reference

title

Estradiol and neurodegenerative oxidative stress (English)

1 reference

18 August 2017

1 reference

Jon Nilsen

1

1 reference

18 August 2017

11 January 2008

1 reference

Frontiers in Neuroendocrinology

18 August 2017

13

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

18 August 2017

29

1 reference

18 August 2017

4

1 reference

18 August 2017

463-475

1 reference

The role of oxidative stress in the pathophysiology of cerebrovascular lesions in Alzheimer's disease

18 August 2017

2 references

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

inferred from DOI database lookup

7 January 2021

based on heuristic

Estradiol prevents neural tau hyperphosphorylation characteristic of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Oxidants, antioxidants, and the degenerative diseases of aging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

The use of okadaic acid in vivo and the induction of molecular changes typical for Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

β-estradiol influences differentiation of hippocampal neurons in vitro through an estrogen receptor-mediated process

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Regulation of antioxidant enzyme activities in male and female rat macrophages by sex steroids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Early postmenopausal hormone therapy may prevent cognitive impairment later in life

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Estrogen-replacement therapy and Alzheimer's disease in the Italian Longitudinal Study on Aging.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Interactions between estrogens and catechol amines. 3. Studies on the methylation of catechol estrogens, catechol amines and other catechols by the ctechol-O-methyltransferases of human liver

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Mitochondrial dysfunction in neurodegenerative diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

The female sex hormone oestrogen as a neuroprotectant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

17-beta estradiol protects neurons from oxidative stress-induced cell death in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Neuroprotection against oxidative stress by estrogens: structure-activity relationship

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Induction of Alzheimer antigens by an uncoupler of oxidative phosphorylation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Inherent abnormalities in energy metabolism in Alzheimer disease. Interaction with cerebrovascular compromise

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Mitochondria from females exhibit higher antioxidant gene expression and lower oxidative damage than males.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

17 beta-Estradiol enhances the outgrowth and survival of neocortical neurons in culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

The women's health initiative estrogen replacement therapy is neurotrophic and neuroprotective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

The Ca2+ influx induced by beta-amyloid peptide 25-35 in cultured hippocampal neurons results from network excitation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Monooxygenase mediating catecholestrogen formation by rat anterior pituitary is an estrogen-4-hydroxylase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Lipid peroxidation and protein oxidation in Alzheimer's disease brain: potential causes and consequences involving amyloid beta-peptide-associated free radical oxidative stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Mitochondrial free radical generation, oxidative stress, and aging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Mitochondrial involvement in brain function and dysfunction: relevance to aging, neurodegenerative disorders and longevity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

beta-Amyloid fragment 25-35 selectively decreases complex IV activity in isolated mitochondria.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Beta-amyloid inhibits integrated mitochondrial respiration and key enzyme activities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part II: dihydropyrimidinase-related protein 2, alpha-enolase and heat shock cognate 71.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Molecular origin of cancer: catechol estrogen-3,4-quinones as endogenous tumor initiators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Dose and temporal pattern of estrogen exposure determines neuroprotective outcome in hippocampal neurons: therapeutic implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Glucose deprivation elicits neurofibrillary tangle-like antigenic changes in hippocampal neurons: prevention by NGF and bFGF

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Ionic dependence of glutamate neurotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

beta-Amyloid neurotoxicity: a discussion of in vitro findings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Tissue distribution and quantitative analysis of estrogen receptor-alpha (ERalpha) and estrogen receptor-beta (ERbeta) messenger ribonucleic acid in the wild-type and ERalpha-knockout mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Copper-dependent inhibition of human cytochrome c oxidase by a dimeric conformer of amyloid-beta1-42.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Cu(II) potentiation of Alzheimer Abeta1-40 cytotoxicity and transition on its secondary structure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Nitric oxide and nitric oxide synthase in Huntington's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Biochemical and molecular characterization of neurofibrillary degeneration in frontotemporal dementias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

MARKing tau for tangles and toxicity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Estradiol protects against ischemic injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Estrogen receptor alpha, not beta, is a critical link in estradiol-mediated protection against brain injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Overexpression of tau protein inhibits kinesin-dependent trafficking of vesicles, mitochondria, and endoplasmic reticulum: implications for Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Iron-induced oxidative stress modify tau phosphorylation patterns in hippocampal cell cultures.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Rapid activation of MAP kinase by estrogen in the bone cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Estrogen-enhanced neurite growth: evidence for a selective induction of Tau and stable microtubules

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Tau and Alzheimer's disease: the long road to anti-tangle therapeutics.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Oxidative regulation of fatty acid-induced tau polymerization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Effects of oestradiol, testosterone and medroxyprogesterone on subcellular fraction marker enzyme activities from rat liver and brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Effect of the lipid peroxidation product acrolein on tau phosphorylation in neural cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Estrogen-induced cell signalling in a cellular model of Alzheimer’s disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Excitatory amino acids and Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Neuroprotective effects of estrogens: potential mechanisms of action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Phenolic A ring requirement for the neuroprotective effects of steroids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Nuclear estrogen receptor-independent neuroprotection by estratrienes: a novel interaction with glutathione

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Mitochondrial calcium transport: physiological and pathological relevance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Microsome-mediated 8-hydroxylation of guanine bases of DNA by steroid estrogens: correlation of DNA damage by free radicals with metabolic activation to quinones

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Mitochondrial respiratory chain-dependent generation of superoxide anion and its release into the intermembrane space

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Glutamate receptor-induced 45Ca2+ accumulation in cortical cell culture correlates with subsequent neuronal degeneration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Testosterone increases and estradiol decreases middle cerebral artery occlusion lesion size in male rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

The epidemiology of estrogen replacement therapy and Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Decreased estrogen receptor-alpha expression in hippocampal neurons in relation to hyperphosphorylated tau in Alzheimer patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Estrogen, synaptic plasticity and hypothalamic reproductive aging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Estrogen-induced activation of mitogen-activated protein kinase requires mobilization of intracellular calcium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Glycogen synthase kinase 3β is identical to tau protein kinase I generating several epitopes of paired helical filaments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

The putative role of free radicals in the loss of neuronal functioning in senescence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Estrogen use and verbal memory in healthy postmenopausal women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore Longitudinal Study of Aging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

17Beta-estradiol attenuates oxidative impairment of synaptic Na+/K+-ATPase activity, glucose transport, and glutamate transport induced by amyloid beta-peptide and iron

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Neuroprotective effects of estrogen against beta-amyloid toxicity are mediated by estrogen receptors in cultured neuronal cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Cloning of a novel receptor expressed in rat prostate and ovary

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

NMDA-dependent superoxide production and neurotoxicity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Mitochondrial regulation of synaptic plasticity in the hippocampus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Free radical generation by redox cycling of estrogens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Involvement of aberrant glycosylation in phosphorylation of tau by cdk5 and GSK-3beta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Acrolein is increased in Alzheimer's disease brain and is toxic to primary hippocampal cultures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Estrogen receptor alpha-immunoreactive astrocytes are increased in the hippocampus in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Colocalization and alteration of estrogen receptor-alpha and -beta in the hippocampus in Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Anovulation in female rats induced by neonatal administration of the catechol estrogens, 2-hydroxy-estradiol and 4-hydroxy-estradiol.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Concentration dependence of prooxidant and antioxidant properties of catecholestrogens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Therapeutic opportunities in Alzheimer disease: one for all or all for one?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Calcium as sculptor and destroyer of neural circuitry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Estrogens stabilize mitochondrial function and protect neural cells against the pro-apoptotic action of mutant presenilin-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Estrogen actions throughout the brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Characterization of tau phosphorylation in glycogen synthase kinase-3beta and cyclin dependent kinase-5 activator (p23) transfected cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Immunolocalization of Estrogen Receptor β in the Mouse Brain: Comparison with Estrogen Receptor α

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Stopped-flow investigation of antioxidant activity of estrogens in solution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Regulation of prostatic glutathione-peroxidase (GSH-PO) in rats treated with a combination of testosterone and 17 beta-estradiol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

The cellular effects of estrogens on neuroendocrine tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Novel and potent biological antioxidants on membrane phospholipid peroxidation: 2-hydroxy estrone and 2-hydroxy estradiol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Mechanism of estrogen-mediated neuroprotection: regulation of mitochondrial calcium and Bcl-2 expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Mitochondria as therapeutic targets of estrogen action in the central nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Estrogen-regulated developmental neuronal apoptosis is determined by estrogen receptor subtype and the Fas/Fas ligand system.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Dual action of estrogen on glutamate-induced calcium signaling: mechanisms requiring interaction between estrogen receptors and src/mitogen activated protein kinase pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Estrogen protects neuronal cells from amyloid beta-induced apoptosis via regulation of mitochondrial proteins and function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Cdk5 is a key factor in tau aggregation and tangle formation in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

The effects of beta-estradiol on SHSY5Y neuroblastoma cells during heavy metal induced oxidative stress, neurotoxicity and beta-amyloid secretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Neurotoxic Abeta peptides increase oxidative stress in vivo through NMDA-receptor and nitric-oxide-synthase mechanisms, and inhibit complex IV activity and induce a mitochondrial permeability transition in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Phosphorylated, but not native, tau protein assembles following reaction with the lipid peroxidation product, 4-hydroxy-2-nonenal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Estrogen modulates neuronal Bcl-xL expression and beta-amyloid-induced apoptosis: relevance to Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Glutamate-induced calcium transient triggers delayed calcium overload and neurotoxicity in rat hippocampal neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Estrogen replacement therapy and memory in older women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Glutamate and the pathophysiology of hypoxic--ischemic brain damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

The O-methylation of 4-hydroxyestradiol is inhibited by 2-hydroxyestradiol: implications for estrogen-induced carcinogenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Catalysis of the oxidation of steroid and stilbene estrogens to estrogen quinone metabolites by the beta-naphthoflavone-inducible cytochrome P450 IA family.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Hippocampal estrogen beta-receptor immunoreactivity is increased in Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Gomori-positive astrocytes: Biological properties and implications for neurologic and neuroendocrine disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Estrogen replacement therapy in older women: a neuropsychological and brain MRI study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Amyloid beta-protein and the genetics of Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Alzheimer's disease results from the cerebral accumulation and cytotoxicity of amyloid beta-protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

An in vitro model of Parkinson's disease: linking mitochondrial impairment to altered alpha-synuclein metabolism and oxidative damage.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Estrogen and Cognitive Functioning in Women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Oxidative damage and mitochondrial decay in aging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Protein turnover by the proteasome in aging and disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Evidence for novel estrogen binding sites in the rat hippocampus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Estrogen binding and estrogen receptor characterization (ERalpha and ERbeta) in the cholinergic neurons of the rat basal forebrain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Role of reactive oxygen species in biological processes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Estrogen protects primary cortical neurons from glutamate toxicity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Modulation of Bcl-2 expression: a potential component of estrogen protection in NT2 neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

The mitogen-activated protein kinase pathway mediates estrogen neuroprotection after glutamate toxicity in primary cortical neurons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Ovarian hormones elicit phosphorylation of Akt and extracellular-signal regulated kinase in explants of the cerebral cortex.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Estrogen-induced activation of mitogen-activated protein kinase in cerebral cortical explants: convergence of estrogen and neurotrophin signaling pathways.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Amyloid-beta, tau alterations and mitochondrial dysfunction in Alzheimer disease: the chickens or the eggs?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Trace amounts of copper in water induce beta-amyloid plaques and learning deficits in a rabbit model of Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Mitogen inactivation of glycogen synthase kinase-3 beta in intact cells via serine 9 phosphorylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Mechanism of O2- generation in reduction and oxidation cycle of ubiquinones in a model of mitochondrial electron transport systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

DNA damage induced by catecholestrogens in the presence of copper (II): generation of reactive oxygen species and enhancement by NADH.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Novel mechanisms of estrogen action in the brain: new players in an old story.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Cell-permeant Ca2+ chelators reduce early excitotoxic and ischemic neuronal injury in vitro and in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Sequestration of glutamate-induced Ca2+ loads by mitochondria in cultured rat hippocampal neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Estradiol protects against ATP depletion, mitochondrial membrane potential decline and the generation of reactive oxygen species induced by 3-nitroproprionic acid in SK-N-SH human neuroblastoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

High molecular weight neurofilament proteins are physiological substrates of adduction by the lipid peroxidation product hydroxynonenal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Induction of nuclear catechol-O-methyltransferase by estrogens in hamster kidney: implications for estrogen-induced renal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Transient cerebral ischemia induces aberrant neuronal cell cycle re-entry and Alzheimer's disease-like tauopathy in female rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Mitochondrial depolarization in glutamate-stimulated neurons: an early signal specific to excitotoxin exposure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Estradiol is a protective factor in the adult and aging brain: understanding of mechanisms derived from in vivo and in vitro studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Estradiol mediates fluctuation in hippocampal synapse density during the estrous cycle in the adult rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Estrogen therapy in postmenopausal women: effects on cognitive function and dementia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Estrogen receptor subtypes alpha and beta contribute to neuroprotection and increased Bcl-2 expression in primary hippocampal neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

Neuroprotective and neurotrophic efficacy of phytoestrogens in cultured hippocampal neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2007.12.005

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YFRNE.2007.12.005

1 reference

18 August 2017

1 reference

PubMed ID

18275991